Assure (IONM) Competitors

Assure (NASDAQ:IONM) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends, valuation and community ranking.

Is IONM or BIOL more profitable?

BIOLASE has a net margin of -41.65% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Assure	-25,178.32%	N/A	-249.78%
BIOLASE	-41.65%	-1,782.73%	-55.31%

Do institutionals and insiders believe in IONM or BIOL?

3.3% of Assure shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 3.8% of Assure shares are held by insiders. Comparatively, 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community believe in IONM or BIOL?

BIOLASE received 289 more outperform votes than Assure when rated by MarketBeat users. Likewise, 52.71% of users gave BIOLASE an outperform vote while only 27.27% of users gave Assure an outperform vote.

Company	Underperform	Outperform
Assure	Outperform Votes 3 27.27%	Underperform Votes 8 72.73%
BIOLASE	Outperform Votes 292 52.71%	Underperform Votes 262 47.29%

Do analysts recommend IONM or BIOL?

BIOLASE has a consensus price target of $1.20, indicating a potential upside of 15,900.00%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts plainly believe BIOLASE is more favorable than Assure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BIOLASE	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Which has more risk & volatility, IONM or BIOL?

Assure has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.

Which has better earnings and valuation, IONM or BIOL?

BIOLASE has higher revenue and earnings than Assure.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$149K	1.08	-$26.08M	N/A	N/A
BIOLASE	$48.83M	0.01	-$20.63M	-$14.94	0.00

Does the media favor IONM or BIOL?

In the previous week, Assure's average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score.

Company	Overall Sentiment
Assure	Neutral
BIOLASE	Neutral

Summary

BIOLASE beats Assure on 10 of the 14 factors compared between the two stocks.